Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...

Congestive Heart Failure (CHF) is a prevalent cardiovascular disorder that requires early detection for effective management. This paper presents a comprehensive framework leveraging Bidirectional ...

A cardiologist reveals a surprising, often overlooked cause of heart failure that’s missed during check-ups, but early detection can make all the difference.

Background: Chagas disease, resulting from the protozoan Trypanosoma cruzi, is an important cause of heart failure, stroke, arrhythmia, and sudden death. Traditionally regarded as a tropical disease ...

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...

The Weight–Heart Failure Connection Heart failure is the organ’s inability to keep up efficiently with the demands placed on it. And it’s becoming more and more common, Ndumele says. “Lots of factors ...

Aims We conducted a meta-analysis of randomised controlled trials (RCTs) of implantable haemodynamic monitoring (IHM)-guided care. Methods PubMed and Ovid MEDLINE were searched for RCTs of IHM in ...